CU23370A3 - ORAL DOSE FORM CONTAINING A PDE 4 INHIBITOR AS AN ACTIVE INGREDIENT AND POLYVINROL PIRROLIDONE AS EXCIPIENT - Google Patents

ORAL DOSE FORM CONTAINING A PDE 4 INHIBITOR AS AN ACTIVE INGREDIENT AND POLYVINROL PIRROLIDONE AS EXCIPIENT

Info

Publication number
CU23370A3
CU23370A3 CU20040176A CU20040176A CU23370A3 CU 23370 A3 CU23370 A3 CU 23370A3 CU 20040176 A CU20040176 A CU 20040176A CU 20040176 A CU20040176 A CU 20040176A CU 23370 A3 CU23370 A3 CU 23370A3
Authority
CU
Cuba
Prior art keywords
pde
inhibitor
polyvinrol
pirrolidone
excipient
Prior art date
Application number
CU20040176A
Other languages
Spanish (es)
Inventor
Hartmut Ney
Klaus Eistetter
Rango Dietrich
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Priority to CU20040176A priority Critical patent/CU23370A3/en
Publication of CU23370A3 publication Critical patent/CU23370A3/en

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describen formas de dosificación para administración oral de un inhibidor de PDE 4 cuya solubilidad es ligera. Contienen PVP como aglutinante.Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as a binder.

CU20040176A 2004-08-17 2004-08-17 ORAL DOSE FORM CONTAINING A PDE 4 INHIBITOR AS AN ACTIVE INGREDIENT AND POLYVINROL PIRROLIDONE AS EXCIPIENT CU23370A3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU20040176A CU23370A3 (en) 2004-08-17 2004-08-17 ORAL DOSE FORM CONTAINING A PDE 4 INHIBITOR AS AN ACTIVE INGREDIENT AND POLYVINROL PIRROLIDONE AS EXCIPIENT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20040176A CU23370A3 (en) 2004-08-17 2004-08-17 ORAL DOSE FORM CONTAINING A PDE 4 INHIBITOR AS AN ACTIVE INGREDIENT AND POLYVINROL PIRROLIDONE AS EXCIPIENT

Publications (1)

Publication Number Publication Date
CU23370A3 true CU23370A3 (en) 2009-04-14

Family

ID=40625057

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20040176A CU23370A3 (en) 2004-08-17 2004-08-17 ORAL DOSE FORM CONTAINING A PDE 4 INHIBITOR AS AN ACTIVE INGREDIENT AND POLYVINROL PIRROLIDONE AS EXCIPIENT

Country Status (1)

Country Link
CU (1) CU23370A3 (en)

Similar Documents

Publication Publication Date Title
ECSP045238A (en) ORAL DOSE FORM CONTAINING A PDE 4 INHIBITOR AS AN ACTIVE INGREDIENT AND POLYVINROL PIRROLIDONE AS EXCIPIENT
AR048431A1 (en) GALENIC FORMULATIONS OF ORGANIC COMPOUNDS
ECSP066990A (en) FORMULATIONS WITH CONTROLLED RELEASE OF ACTIVE PRINCIPLE CONTAINING VARDENAFILO
ECSP055569A (en) DOSAGE FORM OF PRAMIPEXOL IN A SINGLE DAILY DOSE
MX2020011961A (en) Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances.
UY29562A1 (en) AMINO BENZOIL HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCEDURES AND APPLICATIONS
CL2011000589A1 (en) Compounds derived from pyrrolidin-2-carboxamide, p53-mdm2 interaction inhibitors; pharmaceutical composition that includes them; and its use in the preparation of useful medicines for the treatment of cancer.
HRP20041211B1 (en) Topically applicable pharmaceutical preparation
CU23808B7 (en) SOLID PHARMACEUTICAL PRESENTATION FORMS OF ORAL ADMINISTRATION WITH QUICK RELEASE OF ACTIVE PRINCIPLE
AR073077A1 (en) USE OF DABIGATRAN. COMPOUND. PHARMACEUTICAL COMPOSITION-
ECSP077185A (en) PIRIDINE DERIVATIVES
UY29427A1 (en) SUBSTITUTED DERIVATIVES OF 2,3,4,5- TETRAHIDRO-1H-PIRIDO (4,3-B) INDOL, COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
AR117655A1 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION, INCLUDING A DERIVATIVE OF AMINOPYRIMIDINE OR ITS SALT
UY30316A1 (en) SUBSTITUTED DERIVATIVES OF BENZAMIDS, NICOTINAMIDS, PROPANAMIDS, ACETAMIDS AND CARBOXAMIDS N- (2- (PIPERIDIN-1-ILMETIL) CICLOHEXIL) REPLACED, PREPARATION PROCESSES, COMPOSITIONS CONTAINING AND APPLICATIONS
NO20074109L (en) Intravenous formulations of PDE-5 inhibitors
SE0401342D0 (en) Therapeutic compounds
AR070026A1 (en) SET OF ELEMENTS FOR THE DOSAGE OF 1-AMINO-ALQUILCICLOHEXANOS, SUCH AS NERAMEXAN, AND TREATMENT OF DIFFERENT DISEASES INCLUDING TINNITUS
ECSP099767A (en) DERIVATIVES OF N '- (PHENYL) -N- (MORFOLIN-4-IL-PIRIDIN-2-IL) -PIRIMIDINA-2, 4-DIAMINE AS EPHB4 KINASE INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE AFFECTIONS
ECSP22098275A (en) GONADOTROPIN-RELEASING HORMONE ANTAGONIST COMBINATION SOLID ORAL DOSAGE FORMS
UY29561A1 (en) DERIVATIVES OF QUINAZOLINE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCEDURES AND APPLICATIONS
AR053554A1 (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS
MX2022001759A (en) Oral pharmaceutical composition containing heterocyclic compound.
UY29740A1 (en) FORMULATIONS OF HFC DISSOLUTIONS CONTAINING SALBUTAMOL HYDROCHLORIDE OR SALBUTAMOL CITRATE
CO6290762A2 (en) NEW QUINAZOLIN-2, 4-DIONA DERIVATIVES AND A PHARMACEUTICAL COMPOSITION TO PREVENT TREATMENT OF NEUROCEREBRAL DISEASE
CU23370A3 (en) ORAL DOSE FORM CONTAINING A PDE 4 INHIBITOR AS AN ACTIVE INGREDIENT AND POLYVINROL PIRROLIDONE AS EXCIPIENT